Gene interactions and pathways from curated databases and text-mining

◀ Back to SMAD3

CDK2 — SMAD3

Pathways - manually collected, often from reviews:

  • OpenBEL Selventa BEL large corpus: SMAD3 → CDK2 (directlyIncreases, SMAD3 Activity)
    Evidence: 15241418;15520018;10197981
  • OpenBEL Selventa BEL large corpus: SMAD3 → CDK2 (directlyIncreases, SMAD3 Activity)
    Evidence: 15241418;15520018;10197981;16156666

Protein-Protein interactions - manually collected from original source literature:

Studies that report less than 10 interactions are marked with *

Text-mined interactions from Literome

Tomic et al., Biol Reprod 2002 (Body Weight) : Further, the results indicate that Smad 3 may regulate the expression of Bax and Bcl-2, but not Bcl-x, Cdk-2 , and PCNA
Zelivianski et al., Mol Cancer Res 2010 (Breast Neoplasms) : Inhibition of CDK mediated Smad3 phosphorylation released cyclin D1-regulated blockade of Smad3 transcriptional activity and recovered cell cycle arrest in breast cancer cells
Cooley et al., Cell cycle (Georgetown, Tex.) 2010 (Breast Neoplasms) : Overexpression of the cell cycle mitogen, cyclin E, is associated with poor prognosis in breast cancer, and cyclin E/CDK2 mediated phosphorylation of Smad3 has been linked with inhibition of Smad3 activity ... Thus, cyclin E-mediated inhibition of Smad3 is regulated by CDK2 phosphorylation of the Smad3 protein in MCF7 cells
Cheng et al., Chem Biol 2012 (MAP Kinase Signaling System) : We found that indirubin derivative E738 inhibited both TGFß and BMP pathways through ubiquitin-proteasome mediated depletion of total R-Smad pools, although phospho-R-Smad levels were initially stabilized by GSK3ß and cyclin dependent kinase inhibition